• Thurs news: Novartis not joining weight loss race. Pharma marketing and climate change. Roche flu treatment trial. Cercle’s fund raise for women’s health. ICER looks at GSK COPD drugs. See more on our front page

Pfizer-Backed DEM Bio Launches to Leverage CRISPR in Immuno-Oncology

cafead

Administrator
Staff member
  • cafead   Jun 23, 2022 at 11:02: AM
via DEM BioPharma, backed by an impressive list of investors, debuted Thursday with $70 million that will assist in its efforts to treat cancer with an approach that leverages CRISPR screening and macrophage biology in immuno-oncology.

article source
 

<